AGUIRRE FERNANDO 4

What Happened
Fernando Aguirre, a director of CVS Health (CVS), disposed of a total of 32,000 shares back to the issuer in two transactions. On 2026-05-20 he sold 30,437 shares at $93.78 per share for $2,854,230, and on 2026-05-21 he sold 1,563 shares at $93.50 per share for $146,142 — a combined proceeds of $3,000,372. The Form 4 records these as code "D" (Disposition to the issuer), i.e., a sale/disposition rather than a purchase.

Key Details

• Transaction dates and prices:
  • 2026-05-20: 30,437 shares @ $93.78 = $2,854,230
  • 2026-05-21: 1,563 shares @ $93.50 = $146,142
• Total shares sold: 32,000; total proceeds: $3,000,372.
• Filing: Form 4 filed 2026-05-22 (covers activity on May 20–21); filing appears timely.
• Shares owned after transaction: not specified in the provided extract — see the full Form 4 for post-transaction beneficial ownership.
• Footnotes reported in the filing:
  • F1: Represents weighted average purchase price for this group of purchases, which occurred on the same day. Multiple purchases were conducted, with prices ranging between $93.50 and $94.01 per share.
  • F2: Represents weighted average purchase price of $93.775 per share.
• Transaction code: D = Disposition to issuer.

Context
A "disposition to the issuer" means the shares were transferred back to the company (for example, sales to the company or surrender of shares), but the Form 4 here does not state the reason. Such dispositions are common for vesting-related sell-to-cover or other plan-related transfers; the filing itself does not imply the director’s view of the company. For full details (post-transaction ownership, whether the disposition related to awards or tax withholding, or any accompanying purchases referenced by the footnotes), review the complete Form 4 filing (Accession: 0000064803-26-000084).